GOLDENBIOTECH

To treat serious diseases by transferring biomedical breakthrough technologies to the global healthcare community... To demonstrate proof of principle in treating serious diseases in our target areas of drug delivery and biomaterials, prior to seeking outside support for further development... We have over 30 years of diverse experience in polymeric drug delivery systems, stable protein/peptide formulation design, combination product/device delivery, and polymeric biomaterials. Our efforts at Amgen and Ciba-Geigy (now Novartis) led to development of several product candidates useful for the biopharmaceutical, vision care, and agricultural areas. Two of these candidates became marketed products. One is a soft crosslinked polymeric hydrogel contact lens and the other is the long circulating PEGylated protein Neulasta, a multi-billion dollar a year product, which grew out of our site-specific modification know-how.

Also known as: GoldenBiotech, LLC

Primary location: Newbury Park United States